The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. SARS-CoV-2 in-vitro neutralization assay reveals inhibition of virus entry by iota-carrageenan

    1. Martina Morokutti-Kurz
    2. Philipp Graf
    3. Andreas Grassauer
    4. Eva Prieschl-Grassauer

    Reviewed by ScreenIT

    3 evaluationsAppears in 1 listLatest version Latest activity

  2. Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity

    1. João Fadista
    2. Luke M. Kraven
    3. Juha Karjalainen
    4. Shea J. Andrews
    5. Frank Geller
    6. J Kenneth Baillie
    7. Louise V. Wain
    8. R.Gisli Jenkins
    9. Bjarke Feenstra

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease

    1. Ethan G. Brown
    2. Lana M. Chahine
    3. Samuel M. Goldman
    4. Monica Korell
    5. Emerald Mann
    6. Daniel R. Kinel
    7. Vanessa Arnedo
    8. Kenneth L. Marek
    9. Caroline M. Tanner

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Remdesivir is a delayed translocation inhibitor of SARS CoV-2 replication in vitro

    1. Jack P. K. Bravo
    2. Tyler L. Dangerfield
    3. David W. Taylor
    4. Kenneth A. Johnson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Mathematical Modelling the Impact Evaluation of Lockdown on Infection Dynamics of COVID-19 in Italy

    1. S. Kadyrov
    2. A. Orynbassar
    3. H.B Saydaliyev
    4. D. Yergesh

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  6. Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada

    1. Thomas N. Vilches
    2. Kevin Zhang
    3. Robert Van Exan
    4. Joanne M. Langley
    5. Seyed M. Moghadas

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. A Cross-Sectional Survey of the Workplace Factors Contributing to Symptoms of Anxiety and Depression Among Nurses and Physicians During the First Wave of COVID-19 Pandemic in Two US Healthcare Systems

    1. Igor Burstyn
    2. Karyn Holt

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. COVID-19 serological survey using micro blood sampling

    1. Melissa M. Matthews
    2. Tae Gyun Kim
    3. Satoshi Shibata
    4. Noriko Shibata
    5. Christian Butcher
    6. Jaekyung Hyun
    7. Keon Young Kim
    8. Theodore Robb
    9. Siang Sheng Jheng
    10. Masashi Narita
    11. Tomoari Mori
    12. Mary Collins
    13. Matthias Wolf

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge

    1. Mimi Guebre-Xabier
    2. Nita Patel
    3. Jing-Hui Tian
    4. Bin Zhou
    5. Sonia Maciejewski
    6. Kristal Lam
    7. Alyse D. Portnoff
    8. Michael J. Massare
    9. Matthew B. Frieman
    10. Pedro A. Piedra
    11. Larry Ellingsworth
    12. Gregory Glenn
    13. Gale Smith

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma

    1. Peter Vandeberg
    2. Maria Cruz
    3. José María Diez
    4. W. Keither Merritt
    5. Benjamin Santos
    6. Susan Trukawinski
    7. Andrea Wellhouse
    8. Marta José
    9. Todd Willis

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 1758 of 2361 Older